Sean Carrick Nascent Biotech Inc. (NBIO) insider trading activity

NBIO Quotes by TradingView

Sean Carrick is President & CEO of Nascent Biotech Inc.. Currently has a direct ownership of 23.1 Million shares of NBIO, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2024, when has been sold 192,000 shares (Common Stock) at a price of $0.09 per share, resulting in proceeds of $17,280. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.1M
0% 3M change
0.84% 12M change
Total Value Held $0

Sean Carrick Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2024
BUY
Other acquisition or disposition
$17,280 $0.09 p/Share
192,000 Added 0.82%
23,126,007 Common Stock
Mar 31 2024
BUY
Other acquisition or disposition
$40,500 $0.18 p/Share
225,000 Added 0.97%
22,934,007 Common Stock
Dec 29 2023
BUY
Other acquisition or disposition
$40,681 $0.17 p/Share
239,300 Added 1.04%
22,709,007 Common Stock
Sep 29 2023
BUY
Other acquisition or disposition
$332,712 $0.12 p/Share
2,772,600 Added 10.98%
22,469,707 Common Stock
Jun 29 2023
SELL
Bona fide gift
$48,000 $0.05 p/Share
960,000 Reduced 4.65%
19,697,107 Common Stock
Mar 31 2023
BUY
Other acquisition or disposition
$70,020 $0.06 p/Share
1,167,000 Added 5.72%
19,233,607 Common Stock
Dec 30 2022
BUY
Other acquisition or disposition
$92,400 $0.2 p/Share
462,000 Added 2.49%
18,071,607 Common Stock
Mar 31 2022
BUY
Other acquisition or disposition
$25,800 $0.06 p/Share
430,000 Added 2.4%
17,451,131 Common Stock
Mar 09 2022
BUY
Other acquisition or disposition
$50,000 $0.05 p/Share
1,000,000 Added 5.55%
17,021,131 Common Stock
Jun 30 2021
BUY
Other acquisition or disposition
$34,740 $0.1 p/Share
347,400 Added 2.12%
16,021,131 Common Stock
Jun 30 2021
BUY
Other acquisition or disposition
$34,740 $0.1 p/Share
347,400 Added 2.12%
16,021,131 Common Stock
Mar 31 2021
BUY
Other acquisition or disposition
$97,200 $0.06 p/Share
1,620,000 Added 9.37%
15,673,731 Common Stock
Mar 26 2021
BUY
Other acquisition or disposition
$75,000 $0.06 p/Share
1,250,000 Added 8.17%
14,048,731 Common Stock
Dec 31 2020
BUY
Other acquisition or disposition
$144,200 $0.05 p/Share
2,884,000 Added 18.38%
12,803,731 Common Stock
Sep 30 2020
BUY
Other acquisition or disposition
$21,872 $0.1 p/Share
218,715 Added 2.16%
9,919,731 Common Stock
SC

Sean Carrick

President & CEO
San Diego, CA

Track Institutional and Insider Activities on NBIO

Follow Nascent Biotech Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIO shares.

Notify only if

Insider Trading

Get notified when an Nascent Biotech Inc. insider buys or sells NBIO shares.

Notify only if

News

Receive news related to Nascent Biotech Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBIO